Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. E.A. (Esmée) Dijkstra

Publicaties

Authors' reply - A sensitivity analysis of the RAPIDO clinical trial

Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer?: No, it does not

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial

Optimizing the treatment of locally advanced and recurrent rectal cancer

Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial

The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer: results from the RAPIDO trial

Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer – the RAPIDO trial

Clinical selection strategy for and evaluation of intra-operative brachytherapy in patients with locally advanced and recurrent rectal cancer

Interpreting the RAPIDO trial: factors to consider Reply

Quality of life, functional outcome and late toxicity in patients treated within the RAPIDO trial

Lees meer